Please login to the form below

Not currently logged in
Email:
Password:

JMC Partners strengthens senior team

Appoints Andrew Bonser as director, policy andprojects

JMC Partners Andrew BonserLondon-based communications consultancy JMC Partners has appointed former Pfizer policy and government affairs director Andrew Bonser as director, policy and projects.

John Murray, managing director of JMC, said: “Andrew's arrival consolidates our position in the vanguard of healthcare policy. In particular, his knowledge of primary care will prove invaluable as the NHS and local government increasingly come together.”

Bonser was most recently director of public policy at Walgreens Boots Alliance, a role he had held since 2010 and which saw him hold public policy responsibilities across its retail and healthcare interests.

Prior that that Bonser served industry-side at Pfizer Global Pharmaceuticals as European government affairs director, having worked for the company as its director of European trade policy before that.

He said: “JMC has one of the most exciting client lists in healthcare and I look forward to bringing my expertise to bear in helping them achieve success at a time of great challenge and opportunity.”

24th September 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics